Vial, Thierry

The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study

Weber-Schoendorfer, C., Hannemann, D., Meister, R., Eléfant, E., Cuppers-Maarschalkerweerd, B., Arnon, J., Vial, T., Rodriguez-Pinilla, E., Clementi, M., Robert-Gnansia, E., et al. (2008) · Reproductive Toxicology

Pregnancy and Medication ImpactPharmacological Effects and Toxicity Studies

Cited by 104

Safety profile of etifoxine: A French pharmacovigilance survey

Cottin, J., Gouraud, A., Jean‐Pastor, M., Dautriche, A. D., Boulay, C., Geniaux, H., Auffret, M., Bernard, N., Descotes, J., & Vial, T. (2016) · Fundamental & Clinical Pharmacology

Pharmacovigilance and Adverse Drug ReactionsDrug-Induced Adverse Reactions

Cited by 22

Guillain-Barré syndrome associated with COVID-19 vaccines: a perspective from spontaneous report data

Atzenhoffer, M., Auffret, M., Pegat, A., Masmoudi, K., Khouri, C., Bertin, B., & Vial, T. (2022) · Clinical Drug Investigation

Peripheral Neuropathies and DisordersPharmacovigilance and Adverse Drug Reactions

Cited by 20

37 Drugs that act on the immune system: cytokines and monoclonal antibodies

Vial, T., Descotes, J., Braun, F., & Behrend, M. (2007) · Side effects of drugs annual

Immunotoxicology and immune responsesNeutropenia and Cancer Infections

Cited by 3